The identified CK2α-BMI1 liaison is of clinical significance as high CK2α expression strongly correlates with the elevated BMI1 protein levels in high grade serous ovarian cancer tissues. This evidence concerns the gene BMI1 and ovarian serous adenocarcinoma.